Oviva, the digital health scaleup which provides diet and lifestyle coaching has announced that it has raised €67 million ($80m) in Series C funding to expand its digital diabetes treatment across Europe.
The round was co-led by Sofina and Temasek, alongside existing investors AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, and several angel investors.
WHY IT MATTERS
In Europe,...
Switzerland-based Type 2 diabetes treatment provider Oviva announced it has raised $21 million (€18.8 million) in Series B funding.
The round was led by Swiss healthtech investor MTIP, joined by Earlybird as new investors. Existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech all participated.
It brings the total amount raised by Oviva to date to $34 million (€30.5...
